[{"Assets_0_Q2_USD":446906000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":19035000.0,"NetIncomeLoss_1_Q2_USD":6585000.0,"NetIncomeLoss_2_Q2_USD":7034000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":11851000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":11799000.0,"StockholdersEquity_0_Q2_USD":207656000.0,"EarningsPerShareBasic_1_Q2_USD":0.55,"EarningsPerShareBasic_2_Q2_USD":0.59,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]